Here’s a roundup of some of Wednesday’s major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck’s experimental heart drug appears to work well without side…
Under the threat of an FDA ban, the makers of alcoholic energy drink Four Loko are changing its recipe to remove caffeine, guarana and taurine. But the only problem a ban of Four Loko would solve is to save young people from th…
U.S. regulators have decided to ban caffeinated alcoholic beverage such as Four Loko, on the grounds that they are unsafe. Five states have already prohibited sales of such drinks.
Continue reading U.S. Regulat…
Pfizer’s cancer drug crizotinib was able to shrink tumors of non-small-cell lung cancer patients whose tumors carried a specific genetic mutation that fuses two genes. The early-stage study results were published in the New Eng…
Jazz Pharmaceuticals shares slumped more than 5% in premarket trading Monday after the company announced that the FDA had denied approval for its fibromyalgia treatment, sodium oxybate. While approved to treat narcolepsy, sodi…